Evidence map›Paper›PMID 42646697›Full record

ArticleVaccines2026

Association Between Immunosuppressive Cell Populations and Immune Response to Influenza Vaccination in Younger and Older Adults.

Daniela Di Placido, Antonio Ciaramella, Antonella Riccomi, Claudia Maria Trombetta, Maria Dorrucci, Francesca Farchi, Roberto Giuseppetti, Serena Marchi, Nunzia Sanarico, Patrizio Pezzotti and 4 more

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniela Di PlacidoDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.ORCID 0009-0003-2274-9039
Antonio CiaramellaDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.ORCID 0000-0001-9888-8156
Antonella RiccomiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.
Claudia Maria TrombettaDepartment of Molecular and Development Medicine, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-7229-9919
Maria DorrucciDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.
Francesca FarchiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.
Roberto GiuseppettiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.ORCID 0000-0001-9958-164X
Serena MarchiDepartment of Molecular and Development Medicine, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-6817-2461
Nunzia SanaricoCenter for Control and Evaluation of Medicines, Istituto Superiore di Sanità, 00169 Rome, Italy.
Patrizio PezzottiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.ORCID 0000-0002-0805-2927
Anna Rita CiccaglioneDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.
Emanuele MontomoliDepartment of Molecular and Development Medicine, University of Siena, 53100 Siena, Italy.
Catia ValdarchiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.
Silvia VendettiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00169 Rome, Italy.

Funding

Innovative Medicines Initiative No. 806776
6 · The paper itself

Abstract

backgroundSeasonal influenza vaccination shows highly variable effectiveness across individuals, particularly in older adults, in whom age-related immune decline compromises protective responses.

methodsThis study evaluated immune responses to the 2019/2020 quadrivalent influenza vaccine in 75 individuals aged 25-89 years. Influenza-specific antibody titers and virus-neutralizing activity were measured before and four weeks after vaccination, and participants were stratified as high or low responders.

resultsWe observed that older individuals exhibited increased frequencies of myeloid-derived suppressor cells (MDSCs) and activated regulatory T cells (Treg) expressing HLA-DR and CD38, consistent with enhanced immunosuppressive activity. Importantly, higher levels of these immunoregulatory populations correlated with poor vaccine responsiveness in both adult and older participants. Additionally, circulating T follicular regulatory (Tfr) cells were elevated in older participants and in low responders, whereas T follicular helper (Tfh) cells remained unchanged, resulting in an increased Tfr/Tfh

conclusionsThese findings suggest that immunoregulatory networks, while essential for controlling chronic inflammation during aging, may limit vaccine-induced immunity. Identifying biomarkers such as MDSC frequency, activated Treg phenotype, and Tfr/Tfh balance may contribute to the identification of individuals with different levels of vaccine responsiveness and could help inform future personalized vaccination strategies.

Indexed as

immune response to vaccinationimmunoregulatory cellsinfluenza vaccineMDSCsTreg

Identifiers

PMID42646697
PMCPMC13517497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.